Immunological Heterogeneity in Gastric Cancer: Context-Dependent Role of CD8+ T Cells [0.03%]
胃癌的免疫异质性:CD8⁺T细胞的作用及适用范围
Xiaofei Sun,Zihao Yang,Hongtao Qu et al.
Xiaofei Sun et al.
CD8+ T cell infiltration in gastric cancer shows subtype-dependent prognostic and predictive significance across TCGA molecular subtypes. Its clinical value is context-dependent and requires integrated immune profiling to guide modern chemo...
The Pathological Roles of Cationic Amino Acid Transporters (CATs) in Cancer [0.03%]
阳离子氨基酸转运蛋白(CATs)在癌症中的病理作用
Thant Thant Myo Oo,Yasuhiro Saito
Thant Thant Myo Oo
Cationic amino acid transporters (CATs), encoded by the SLC7A family, play essential roles in the uptake of arginine and other cationic amino acids, thereby regulating cellular metabolism, signaling, and immune responses. Among SLC7A transp...
Tissue Factor-High Ovarian Clear Cell Carcinoma Shows Immune-Cold Features and Preclinical Activity of Tisotumab Vedotin [0.03%]
组织型因子高卵巢透明细胞癌表现出免疫“冷”特征及Tisotumab Vedotin的预临床活性
Yutaro Mori,Ryo Tamura,Kotaro Takahashi et al.
Yutaro Mori et al.
Tissue factor (TF; encoded by F3) is frequently overexpressed in ovarian clear cell carcinoma (OCCC), but the biological features of TF-high tumors and their therapeutic implications remain poorly defined. We analyzed F3-high and F3-low OCC...
Selective Depletion of Tumor-Infiltrating CD4+CCR8+ Tregs by AZ084, a Novel CCR8 Antagonist [0.03%]
新型CCR8拮抗剂AZ084选择性清除肿瘤浸润CD4⁺ CCR8⁺ Treg细胞
Yepeng Mao,Ziqi Tao,Shuna Liu et al.
Yepeng Mao et al.
Regulatory T cells (Tregs) are key mediators of immunosuppression in ovarian cancer, yet strategies for selectively targeting tumor-infiltrating Tregs remain limited. CD4+CCR8+ Tregs have been proposed as a highly suppressive subset, but th...
AI-Based Analysis of Tumor-Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025-A1 Study [0.03%]
基于人工智能的卵巢癌肿瘤浸润淋巴细胞和同源重组分析研究:JGOG3025-A1研究
Kohei Hamada,Junzo Hamanishi,Noriomi Matsumura et al.
Kohei Hamada et al.
Understanding the tumor immune microenvironment, especially tumor-infiltrating lymphocytes (TILs), remains crucial in ovarian cancer. However, the distribution and prognostic significance of TILs across histological subtypes and genetic bac...
YBX1 Promotes Malignant Progression of HNSCC via Stabilizing NSUN2-m5C Modified ATF4 mRNA [0.03%]
YBX1通过稳定ATF4 mRNA促进头颈鳞癌恶性进展
Yanwei Li,Shuang Li,Yang Li et al.
Yanwei Li et al.
Head and neck squamous cell carcinoma (HNSCC) remains a major therapeutic challenge because of its aggressive metastatic behavior and the paucity of effective targeted therapies. The present study identifies YBX1 as a critical 5-methylcytos...
Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort [0.03%]
基于基因组分析的晚期实体瘤患者二期尼伏单抗治疗试验:BELIEVE试验(NCCH1901)亚组试验
Masashi Kanai,Kuniko Sunami,Tatsunori Shimoi et al.
Masashi Kanai et al.
Comprehensive genomic profiling (CGP) tests can identify putative biomarkers for immune checkpoint inhibitors (ICIs), including tumor mutational burden (TMB); however, their clinical utility remains uncertain. In this study, the efficacy an...
Urinary Small Extracellular Vesicle DNA as a Biomarker for the Non-Invasive Diagnosis of Bladder Cancer [0.03%]
尿液小型细胞外囊泡DNA作为无创性诊断膀胱癌的生物标志物
Tao Wang,Xin Liao,Jiyang Zhang et al.
Tao Wang et al.
Existing diagnostic technologies for bladder cancer (BC) suffer from low sensitivity, low specificity, or a lack of validation. Therefore, validated, non-invasive diagnostic biomarkers with high sensitivity and specificity for early detecti...
Splicing Factor Mutations in Clonal Hematopoiesis and Progression to Myeloid Neoplasms [0.03%]
克隆型血液细胞生成中的剪接因子突变及其向髓系肿瘤的进展
Yang Lyu,Yutong Zhang,Ayana Kon
Yang Lyu
Splicing factor (SF) mutations are recurrent driver alterations in myeloid neoplasms and also represent a distinctive class of mutations in clonal hematopoiesis (CH), an age-associated expansion of hematopoietic clones carrying somatic driv...
Genetic Evolution in BRCA1-Associated Breast Cancer Reveals Early Driver Mutations Shaping Tumor Features and Prognosis [0.03%]
BRCA1相关乳腺癌的基因组进化揭示了早期驱动突变决定了肿瘤特征和预后
Li Hu,Zhongwu Li,Qiting Wan et al.
Li Hu et al.
Pathogenic germline variants in the BRCA1 gene significantly increase the lifetime risk of breast cancer and are frequently associated with early-onset and triple-negative disease. However, the chronology of genetic events during breast tum...